Improve the prognosis of patients with brain tumors through the development of innovative therapeutic ultrasound-based solutions
CarThera announces enrollment of first melanoma patient in new clinical trial for SonoCloud technology
An implant that increases the intracerebral penetration of oncology drugs (+400%) by transiently opening the blood-brain barrier (BBB) without increasing dose or subsequent toxicity. The minimally invasive and easy to use SonoCloud® device is also applicable to the treatment of neurodegenerative diseases (e.g. Alzheimer’s).
The only medical device capable of performing biopsy, treatment, and resection of brain tumors in a single, image-guided outpatient procedure, even for complex tumor geometries
The SonoProbe can also be used for the treatment of tumors located in other organs such as the liver or lung